Effect of Tranilast on restenosis of Arteriovenous Fistulas for Hemodialysis.
Not Applicable
- Conditions
- hemodialysis patients
- Registration Number
- JPRN-UMIN000004251
- Lead Sponsor
- Department of Nephrology and Hypertension, St. Marianna University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
The exclusion criteria are follows; 1) newly receiving the antiplatelet agent or antithrombocytic agent or anticoagulant agent or anticoagulant agent or vasodilating age within three monthes 2) drug allergy to tranilast
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome is number of PTA times for one year after patients receive tranilast.
- Secondary Outcome Measures
Name Time Method The secondary outcome is failure of the fistula or graft determined by ultrasound.